Literature DB >> 23467492

The virus inoculum volume influences outcome of influenza A infection in mice.

Darren S Miller1, Tuckweng Kok, Peng Li.   

Abstract

When establishing animal models of viral respiratory infection, the optimal dose and route of delivery are critical to ensure reproducible outcomes. The mouse model for influenza infection is widely used due to the small animal size and simplicity of viral inoculation. During establishment of a mouse model of influenza A infection we observed a marked shift in morbidity when identical influenza A inoculum doses were delivered in less than 35 μL. We show for the first time that mice challenged with a 25 μL inoculum volume readily recovered following infection with an infectious dose of influenza A virus that was fatal when inoculated in 35 or 50 μL volumes.

Entities:  

Mesh:

Year:  2013        PMID: 23467492     DOI: 10.1258/la.2012.011157

Source DB:  PubMed          Journal:  Lab Anim        ISSN: 0023-6772            Impact factor:   2.471


  11 in total

1.  Smad4 promotes differentiation of effector and circulating memory CD8 T cells but is dispensable for tissue-resident memory CD8 T cells.

Authors:  Yinghong Hu; Young-Tae Lee; Susan M Kaech; Beth Garvy; Linda S Cauley
Journal:  J Immunol       Date:  2015-01-30       Impact factor: 5.422

2.  Severity of clinical disease and pathology in ferrets experimentally infected with influenza viruses is influenced by inoculum volume.

Authors:  Ian N Moore; Elaine W Lamirande; Myeisha Paskel; Danielle Donahue; Heather Kenney; Jing Qin; Kanta Subbarao
Journal:  J Virol       Date:  2014-09-03       Impact factor: 5.103

3.  Comparison of traditional intranasal and aerosol inhalation inoculation of mice with influenza A viruses.

Authors:  Jessica A Belser; Kortney M Gustin; Jacqueline M Katz; Taronna R Maines; Terrence M Tumpey
Journal:  Virology       Date:  2015-03-13       Impact factor: 3.616

4.  Mucosal immunization with a candidate universal influenza vaccine reduces virus transmission in a mouse model.

Authors:  Graeme E Price; Chia-Yun Lo; Julia A Misplon; Suzanne L Epstein
Journal:  J Virol       Date:  2014-03-12       Impact factor: 5.103

5.  Influenza virus inoculum volume is critical to elucidate age-dependent mortality in mice.

Authors:  Candice A Smith; Upasana Kulkarni; Judy Chen; Daniel R Goldstein
Journal:  Aging Cell       Date:  2019-01-11       Impact factor: 9.304

6.  Outcomes of COVID-19 Among Hospitalized Health Care Workers in North America.

Authors:  Jeong Yun Yang; Michael D Parkins; Andrew Canakis; Olga C Aroniadis; Dhiraj Yadav; Rebekah E Dixon; B Joseph Elmunzer; Nauzer Forbes
Journal:  JAMA Netw Open       Date:  2021-01-04

Review 7.  Human gene polymorphisms and their possible impact on the clinical outcome of SARS-CoV-2 infection.

Authors:  Seyed Mohammad Ali Hashemi; Marijn Thijssen; Seyed Younes Hosseini; Alijan Tabarraei; Mahmoud Reza Pourkarim; Jamal Sarvari
Journal:  Arch Virol       Date:  2021-05-02       Impact factor: 2.685

8.  Masks Do More Than Protect Others During COVID-19: Reducing the Inoculum of SARS-CoV-2 to Protect the Wearer.

Authors:  Monica Gandhi; Chris Beyrer; Eric Goosby
Journal:  J Gen Intern Med       Date:  2020-07-31       Impact factor: 5.128

Review 9.  Prioritization of Anti-SARS-Cov-2 Drug Repurposing Opportunities Based on Plasma and Target Site Concentrations Derived from their Established Human Pharmacokinetics.

Authors:  Usman Arshad; Henry Pertinez; Helen Box; Lee Tatham; Rajith K R Rajoli; Paul Curley; Megan Neary; Joanne Sharp; Neill J Liptrott; Anthony Valentijn; Christopher David; Steve P Rannard; Paul M O'Neill; Ghaith Aljayyoussi; Shaun H Pennington; Stephen A Ward; Andrew Hill; David J Back; Saye H Khoo; Patrick G Bray; Giancarlo A Biagini; Andrew Owen
Journal:  Clin Pharmacol Ther       Date:  2020-06-14       Impact factor: 6.903

10.  Recombinant influenza H1, H5 and H9 hemagglutinins containing replaced H3 hemagglutinin transmembrane domain showed enhanced heterosubtypic protection in mice.

Authors:  Qiliang Liu; Kang Liu; Chunyi Xue; Jianqiang Zhou; Xiaoming Li; Dongyu Luo; Jing Zheng; Shun Xu; George Dacai Liu; Yongchang Cao
Journal:  Vaccine       Date:  2014-04-03       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.